<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37631888</PMID><DateRevised><Year>2023</Year><Month>08</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>8</Issue><PubDate><Year>2023</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Effects of Vaccines on the Sequelae Rates of Recurrent Infections and the Severity of Pulmonary COVID-19 Infection by Imaging.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1321</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines11081321</ELocationID><Abstract><AbstractText>Although vaccines have been shown to reduce the number of COVID-19 infection cases significantly, vaccine-related reactions, long COVID-19 syndrome, and COVID-19 infection following vaccination continue to be a burden on healthcare services and warrant further scientific research. The purpose of this study was to research the severity of pulmonary COVID-19 infection following vaccination and the sequelae rates of recurrent infections in vaccinated cases by imaging. Patients who underwent follow-up CTs at 1 month, 3 months, and 6 months in our hospital with a diagnosis of COVID-19 were scanned retrospectively. Furthermore, all essential information was gathered from patients' immunization records. The major findings of our study were: (1) sequelae were frequently observed in unvaccinated cases; (2) the correlation between vaccination status and the severity of sequelae was significant; (3) there was not any significant relationship between the vaccine type and the severity of sequelae; and (4) hematocrit, hemoglobin, and lymphocyte parameters may be used as predictors of sequelae rates. COVID-19 infection, although reduced in prevalence following the development of vaccines, still remains a public health concern because of reinfection. Vaccination not only appears to protect against primary infection, but also seems to reduce reinfection and sequalae rates following reinfection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bahadir</LastName><ForeName>Suzan</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Radiology, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kabacaoglu</LastName><ForeName>Ebru</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Chest Diseases, Baskent University Alanya Research and Training Center, Yunus Emre Avenue, Alanya 07400, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Memis</LastName><ForeName>Kemal Bugra</ForeName><Initials>KB</Initials><Identifier Source="ORCID">0009-0007-6746-3906</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Erzincan Binali Yildirim University, Basbaglar, 1429th Street, Erzincan 24100, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasan</LastName><ForeName>Hasan Ilksen</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Department of Radiology, Fiona Stanley Hospital, 11 Robin Warren Drive, Murdoch, WA 6150, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aydin</LastName><ForeName>Sonay</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-3812-6333</Identifier><AffiliationInfo><Affiliation>Department of Radiology, Erzincan Binali Yildirim University, Basbaglar, 1429th Street, Erzincan 24100, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus disease</Keyword><Keyword MajorTopicYN="N">lung complications</Keyword><Keyword MajorTopicYN="N">reinfection</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword><Keyword MajorTopicYN="N">thorax CT</Keyword><Keyword MajorTopicYN="N">vaccination</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>10</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>26</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37631888</ArticleId><ArticleId IdType="pmc">PMC10458389</ArticleId><ArticleId IdType="doi">10.3390/vaccines11081321</ArticleId><ArticleId IdType="pii">vaccines11081321</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>WHO Coronavirus (COVID-19) Dashboard.  [(accessed on 18 March 2023)].  Available online:  https://covid19.who.int.</Citation></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen K., Ren S., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Guo Y., Lipsitch M., Daugherty S.E. Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2022;376:e068414. doi: 10.1136/bmj-2021-068414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-068414</ArticleId><ArticleId IdType="pmc">PMC8828141</ArticleId><ArticleId IdType="pubmed">35140117</ArticleId></ArticleIdList></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post&#x2013;COVID conditions among adult COVID-19 survivors aged 18&#x2013;64 and &#x2265;65 years&#x2014;United States, March 2020&#x2013;November 2021. MMWR Morb. Mortal. Wkly Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Daugherty S.E., Guo Y., Heath K., Dasmari&#xf1;as M.C., Jubilo K.G., Samranvedhya J., Lipsitch M., Cohen K. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: Retrospective cohort study. BMJ. 2021;373:n1098. doi: 10.1136/bmj.n1098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1098</ArticleId><ArticleId IdType="pmc">PMC8132065</ArticleId><ArticleId IdType="pubmed">34011492</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V., Maddox T., Humberstone B., Diamond I., Banerjee A. Post-covid syndrome in individuals admitted to hospital with Covid-19: Retrospective cohort study. BMJ. 2021;372:n693. doi: 10.1136/bmj.n693.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n693</ArticleId><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y., Bowe B., Al-Aly Z. Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status. Nat. Commun. 2021;12:6571. doi: 10.1038/s41467-021-26513-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26513-3</ArticleId><ArticleId IdType="pmc">PMC8589966</ArticleId><ArticleId IdType="pubmed">34772922</ArticleId></ArticleIdList></Reference><Reference><Citation>Bernardinello N., Cocconcelli E., Giraudo C., Daverio M., Castelli G., Petrarulo S., Bovo M., Fichera G., Cavinato S., Cattelan A.M. Predictors of pulmonary sequelae after COVID-19 pneumonia: A 12-month follow-up study. Front. Med. 2023;10:1084002. doi: 10.3389/fmed.2023.1084002.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1084002</ArticleId><ArticleId IdType="pmc">PMC9932038</ArticleId><ArticleId IdType="pubmed">36817777</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Liu J., Liu M. Effect of COVID-19 vaccines on reducing the risk of long COVID in the real world: A systematic review and meta-analysis. Int. J. Environ. Res. Public Health. 2022;19:12422. doi: 10.3390/ijerph191912422.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191912422</ArticleId><ArticleId IdType="pmc">PMC9566528</ArticleId><ArticleId IdType="pubmed">36231717</ArticleId></ArticleIdList></Reference><Reference><Citation>British Thoracic Society . British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia. British Thoracic Society; London, UK: 2020.</Citation></Reference><Reference><Citation>Watanabe A., So M., Iwagami M., Fukunaga K., Takagi H., Kabata H., Kuno T. One-year follow-up CT findings in COVID-19 patients: A systematic review and meta-analysis. Respirology. 2022;27:605&#x2013;616. doi: 10.1111/resp.14311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/resp.14311</ArticleId><ArticleId IdType="pmc">PMC9350074</ArticleId><ArticleId IdType="pubmed">35694728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao P., Cai S., Liu Q., Du M., Liu J., Liu M. Effectiveness and Safety of SARS-CoV-2 Vaccines among Children and Adolescents: A Systematic Review and Meta-Analysis. Vaccines. 2022;10:421. doi: 10.3390/vaccines10030421.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10030421</ArticleId><ArticleId IdType="pmc">PMC8953823</ArticleId><ArticleId IdType="pubmed">35335053</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynberg E., Han A.X., Boyd A., van Willigen H.D., Verveen A., Lebbink R., van der Straten K., Kootstra N., van Gils M.J., Russell C., et al. The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study. Vaccine. 2022;40:4424&#x2013;4431. doi: 10.1016/j.vaccine.2022.05.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2022.05.090</ArticleId><ArticleId IdType="pmc">PMC9170535</ArticleId><ArticleId IdType="pubmed">35725782</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Xie Y., Al-Aly Z. Acute and postacute sequelae associated with SARS-CoV-2 reinfection. Nat. Med. 2022;28:2398&#x2013;2405. doi: 10.1038/s41591-022-02051-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02051-3</ArticleId><ArticleId IdType="pmc">PMC9671810</ArticleId><ArticleId IdType="pubmed">36357676</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansell D.M., Bankier A.A., MacMahon H., McLoud T.C., Muller N.L., Remy J. Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 2008;246:697&#x2013;722. doi: 10.1148/radiol.2462070712.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2462070712</ArticleId><ArticleId IdType="pubmed">18195376</ArticleId></ArticleIdList></Reference><Reference><Citation>Konopka K.E., Perry W., Huang T., Farver C.F., Myers J.L. Usual interstitial pneumonia is the most common finding in surgical lung biopsies from patients with persistent interstitial lung disease following infection with SARS-CoV-2. EClinicalMedicine. 2021;42:101209. doi: 10.1016/j.eclinm.2021.101209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101209</ArticleId><ArticleId IdType="pmc">PMC8609167</ArticleId><ArticleId IdType="pubmed">34841234</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Qin C., Liu M., Liu J. Effectiveness and safety of SARS-CoV-2 vaccine in real-world studies: A systematic review and meta-analysis. Infect. Dis. Poverty. 2021;10:132. doi: 10.1186/s40249-021-00915-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40249-021-00915-3</ArticleId><ArticleId IdType="pmc">PMC8590867</ArticleId><ArticleId IdType="pubmed">34776011</ArticleId></ArticleIdList></Reference><Reference><Citation>Kow C.S., Hasan S.S. Real-world effectiveness of BNT162b2 mRNA vaccine: A meta-analysis of large observational studies. Inflammopharmacology. 2021;29:1075&#x2013;1090. doi: 10.1007/s10787-021-00839-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00839-2</ArticleId><ArticleId IdType="pmc">PMC8266992</ArticleId><ArticleId IdType="pubmed">34241782</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasreen S., Chung H., He S., Brown K.A., Gubbay J.B., Buchan S.A., Fell D.B., Austin P.C., Schwartz K.L., Sundaram M.E., et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat. Microbiol. 2022;7:379&#x2013;385. doi: 10.1038/s41564-021-01053-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-021-01053-0</ArticleId><ArticleId IdType="pubmed">35132198</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., Alwan N.A., Walker A.S. Trajectory of long COVID symptoms after COVID-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar P., Jat K.R. Post-COVID-19 Sequelae in Children. Indian J. Pediatr. 2023;90:605&#x2013;611. doi: 10.1007/s12098-023-04473-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12098-023-04473-4</ArticleId><ArticleId IdType="pmc">PMC9992903</ArticleId><ArticleId IdType="pubmed">36884145</ArticleId></ArticleIdList></Reference><Reference><Citation>Parimon T., Espindola M., Marchevsky A., Rampolla R., Chen P., Hogaboam C.M. Potential mechanisms for lung fibrosis associated with COVID-19 infection. QJM Int. J. Med. 2023;116:487&#x2013;492. doi: 10.1093/qjmed/hcac206.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcac206</ArticleId><ArticleId IdType="pmc">PMC10382189</ArticleId><ArticleId IdType="pubmed">36018274</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>